Related references
Note: Only part of the references are listed.Development of an analytical method to detect simultaneously 219 new psychoactive substances and 65 other substances in urine specimens using LC-QqQ MS/MS with CriticalPairFinder and TransitionFinder
Ju-Yu Chen et al.
TALANTA (2022)
Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project
Chih-Chuan Lin et al.
CLINICAL TOXICOLOGY (2022)
A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020
Nunzia La Maida et al.
THERAPEUTIC DRUG MONITORING (2021)
Analytically confirmed eutylone (bk-EBDB) exposure in emergency department patients
Hsien-Yi Chen et al.
CLINICAL TOXICOLOGY (2021)
Synthetic cathinone poisoning from ingestion of drug-laced instant coffee packets in Taiwan
H-H Chou et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2021)
An updated review on synthetic cathinones
Jorge Soares et al.
ARCHIVES OF TOXICOLOGY (2021)
Analytically confirmed 4-Methyl-N-ethylnorpentedrone (4-MEAP), a synthetic cathinone, in cases presenting to an emergency department
Te- Weng et al.
CLINICAL TOXICOLOGY (2020)
Clinical manifestation and quantitative urinary analysis of N-ethylnorpentylone abuse in patients to the emergency department
Dean-An Ling et al.
CLINICAL TOXICOLOGY (2020)
Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department
Te- Weng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)
Designer drugs: mechanism of action and adverse effects
Dino Luethi et al.
ARCHIVES OF TOXICOLOGY (2020)
New psychoactive substances in Taiwan: challenges and strategies
Ling-Yi Feng et al.
CURRENT OPINION IN PSYCHIATRY (2020)
Management of pharmaceutical and recreational drug poisoning
Bruno Megarbane et al.
ANNALS OF INTENSIVE CARE (2020)
Synthetic cathinones: an evolving class of new psychoactive substances
Joao L. Goncalves et al.
CRITICAL REVIEWS IN TOXICOLOGY (2019)
Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats
Olof Beck et al.
CLINICAL TOXICOLOGY (2018)
Synthetic cathinones in Southern Germany - characteristics of users, substance-patterns, co-ingestions, and complications
Katrin Romanek et al.
CLINICAL TOXICOLOGY (2017)
Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs
D. M. Wood et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2016)
Creatine kinase in the US population Impact of demographics, comorbidities, and body composition on the normal range
Michael D. George et al.
MEDICINE (2016)
Human Pharmacology of Mephedrone in Comparison with MDMA
Esther Papaseit et al.
NEUROPSYCHOPHARMACOLOGY (2016)
3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter
John H. Anneken et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Effects of Social Interaction and Warm Ambient Temperature on Brain Hyperthermia Induced by the Designer Drugs Methylone and MDPV
Eugene A. Kiyatkin et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison of Stimulants
Ayrn D. O'Connor et al.
JOURNAL OF MEDICAL TOXICOLOGY (2015)
Designer drugs 2015: assessment and management
Michael F. Weaver et al.
ADDICTION SCIENCE & CLINICAL PRACTICE (2015)
Khat and synthetic cathinones: a review
Maria Joao Valente et al.
ARCHIVES OF TOXICOLOGY (2014)
Detection of new psychoactive substance use among emergency room patients: Results from the Swedish STRIDA project
Anders Helander et al.
FORENSIC SCIENCE INTERNATIONAL (2014)
Bath salts and synthetic cathinones: An emerging designer drug phenomenon
Christopher L. German et al.
LIFE SCIENCES (2014)
Pharmacology of novel synthetic stimulants structurally related to the bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)
Julie A. Marusich et al.
NEUROPHARMACOLOGY (2014)
Pharmacological characterization of designer cathinones in vitro
L. D. Simmler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
In vivo Effects of Abused 'Bath Salt' Constituent 3,4-methylenedioxypyrovalerone (MDPV) in Mice: Drug Discrimination, Thermoregulation, and Locomotor Activity
William E. Fantegrossi et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products
Michael H. Baumann et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Adolescent Synthetic Cathinone Exposures Reported to Texas Poison Centers
Mathias B. Forrester
PEDIATRIC EMERGENCY CARE (2013)
Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats
Kurt J. Varner et al.
PSYCHOPHARMACOLOGY (2013)
Mephedrone pharmacokinetics after intravenous and oral administration in rats: relation to pharmacodynamics
J. Martinez-Clemente et al.
PSYCHOPHARMACOLOGY (2013)
Hyperthermia and Multiorgan Failure After Abuse of Bath Salts Containing 3,4-Methylenedioxypyrovalerone
Heather A. Borek et al.
ANNALS OF EMERGENCY MEDICINE (2012)
Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, Meow Meow'') in the United Kingdom
Fabrizio Schifano et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
The Toxicology of Bath Salts: A Review of Synthetic Cathinones
Jane M. Prosser et al.
JOURNAL OF MEDICAL TOXICOLOGY (2012)
Clinical toxicology of newer recreational drugs
Simon L. Hill et al.
CLINICAL TOXICOLOGY (2011)
Toxin-induced hyperthermic syndromes
DE Rusyniak et al.
MEDICAL CLINICS OF NORTH AMERICA (2005)
Share Paper
